Treatment with doxorubicin plus trabectedin (Yondelis), followed by trabectedin maintenance, improved overall survival (OS) and progression-free survival (PFS) in patients with metastatic or ...
Early on-treatment ctDNA dynamics and response by imaging in patients with sarcoma. Circulating free DNA derived from active chromatin as a predictive biomarker for clinical benefit to checkpoint ...
Inferior vena cava leiomyosarcoma is an exceptionally rare malignant tumour originating from the smooth muscle cells of the inferior vena cava (IVC). Characterised by an insidious onset and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results